ECD for Lung Transplantation

  • Yasushi Hoshikawa
  • Yoshinori Okada
  • Tatsuaki Watanabe
  • Takashi Kondo


The short supply of donor organs has been one of the most critical problems in the area of lung transplantation (LTx), and this is especially serious in Japan. One approach to attempt to address this limitation is the use of extended criteria donor (ECD) lungs. The currently accepted criteria for suitable donor lungs (Table 7.1) were instituted in the mid-1980s during the early development of clinical LTx [1]. These criteria were chosen by early transplant physicians and surgeons based on prevailing knowledge of pulmonary physiology, but were not based upon strict scientific evidence [2]. Afterward the ever-increasing number of recipients on waiting lists compelled lung transplant doctors to consider the use of ECD lungs. Liberalization of the donor selection criteria has been gradually accepted worldwide since the mid-1990s [2]. A recent large registry study of more than ten thousand LTxs performed in the USA from 1999 to 2008 revealed that at least one variance from the criteria occurred in more than a half of transplants [3]. Although results have varied among studies, outcomes of LTx using ECD lungs have generally been acceptable [4–18]. However, proper judgment is still difficult if multiple factors are defined extended and if ECD lungs are used in high-risk recipients especially who are rapidly deteriorating on the waiting list. To properly assess and optimize ECD lungs in such circumstances, a new strategy utilizing normothermic ex vivo lung perfusion (EVLP) system has been developed, and the impact of the system on LTx has been explored in several high-flow transplant centers [19, 20].

In Japan, 124 LTxs from deceased donors have been successfully performed as of the end of 2012 [21]. These transplantations achieved a 5-year patient survival rate of 72.0 % and a 10-year survival of 57.3 % [21]. To maximize the lung utilization rate in multiorgan donors, Japan Organ Transplant Network has operated a system involving the partnership of well-trained transplant consultant doctors and local doctors in assessing donor lungs and providing intensive care to donors since 2002 [22]. These consultant doctors tirelessly performed bronchial toileting for donors and provided advice on respiratory therapy, mechanical ventilation, infection controls, and circulatory management of donors. Since such sustained efforts by the consultant doctors in cooperation with local doctors have been made to effectively utilize ECD lungs, the lungs were used for transplantation in more than 60 % of brain-dead donors [22].

This chapter reviews definition and assessment methods of ECD lungs, studies showing outcomes of LTx using ECDs, and progress in recent research regarding ECD lungs.


Intensive Care Unit Stay Bronchiolitis Obliterans Syndrome Donor Lung Primary Graft Dysfunction Longe Intensive Care Unit Stay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sundaresan S, Trachiotis G, Aoe M, Patterson G, Cooper J. Donor lung procurement: assessment and operative technique. Ann Thorac Surg. 1993;56:1409–13.PubMedCrossRefGoogle Scholar
  2. 2.
    Gabbay E, Williams TJ, Griffiths AP, Macfarlane LM, Kotsimbos TC, Esmore DS, Snell GI. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 1999;160(1):265–71.PubMedCrossRefGoogle Scholar
  3. 3.
    Reyes KG, Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Guidelines for donor lung selection: time for revision? Ann Thorac Surg. 2010;89(6):1756–64.PubMedCrossRefGoogle Scholar
  4. 4.
    Kron IL, Tribble CG, Kern JA, Daniel TM, Rose CE, Truwit JD, Blackbourne LH, Bergin JD. Successful transplantation of marginally acceptable thoracic organs. Ann Surg. 1993;217(5):518–22.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Sundaresan S, Semenkovich J, Ochoa L, Richardson G, Trulock EP, Cooper JD, Patterson GA. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995;109(6):1075–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19(12):1199–204.PubMedCrossRefGoogle Scholar
  7. 7.
    Oto T, Griffiths AP, Levvey B, Pilcher DV, Whitford H, Koshimbos TC, Rabinov M, Esmore DS, Williams TJ, Snell GI. A donor history of smoking affects early but not late outcomes in lung transplantation. Transplantation. 2004;78:599–606.PubMedCrossRefGoogle Scholar
  8. 8.
    Thabut G, Mal H, Cerrina J, Dartevelle P, Dromer C, Velly JF, Stern M, Loirat P, Bertocchi M, Mornex JF, Haloun A, Despins P, Pison C, Blin D, Simonneau G, Reynaud-Gaubert M. Influence of donor characteristics on outcome after lung transplantation: a multicenter study. J Heart Lung Transplant. 2005;24(9):1347–53.PubMedCrossRefGoogle Scholar
  9. 9.
    Lardinois D, Banysch M, Korom S, Hillinger S, Rousson V, Boehler A, Speich R, Weder W. Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg. 2005;27(5):762–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Aigner C, Winkler G, Jaksch P, Seebacher G, Lang G, Taghavi S, Wisser W, Klepetko W. Extended donor criteria for lung transplantation–a clinical reality. Eur J Cardiothorac Surg. 2005;27(5):757–61.PubMedCrossRefGoogle Scholar
  11. 11.
    Kawut SM, Reyentovich A, Wilt JS, Anzeck R, Lederer DJ, O'Shea MK, Sonett JR, Arcasoy SM. Outcomes of extended donor lung recipients after lung transplantation. Transplantation. 2005;79(3):310–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Luckraz H, White P, Sharples LD, Hopkins P, Wallwork J. Short- and long-term outcomes of using pulmonary allograft donors with low Po2. J Heart Lung Transplant. 2005;24(4):470–3.PubMedCrossRefGoogle Scholar
  13. 13.
    Botha P, Trivedi D, Weir CJ, Searl CP, Corris PA, Dark JH, Schueler SV. Extended donor criteria in lung transplantation: impact on organ allocation. J Thorac Cardiovasc Surg. 2006;131(5):1154–60.PubMedCrossRefGoogle Scholar
  14. 14.
    De Perrot M, Waddell TK, Shargall Y, Pierre AF, Fadel E, Uy K, Chaparro C, Hutcheon M, Singer LG, Keshavjee S. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg. 2007;133(2):525–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Meers C, Van Raemdonck D, Verleden GM, Coosemans W, Decaluwe H, De Leyn P, Nafteux P, Lerut T. The number of lung transplants can be safely doubled using extended criteria donors; a single-center review. Transpl Int. 2010;23(6):628–35.PubMedCrossRefGoogle Scholar
  16. 16.
    Berman M, Goldsmith K, Jenkins D, Sudarshan C, Catarino P, Sukumaran N, Dunning J, Sharples LD, Tsui S, Parmar J. Comparison of outcomes from smoking and nonsmoking donors: thirteen-year experience. Ann Thorac Surg. 2010;90(6):1786–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Zafar F, Khan MS, Heinle JS, Adachi I, McKenzie ED, Schecter MG, Mallory GB, Morales DL. Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants. J Thorac Cardiovasc Surg. 2012;143(4):919–25.PubMedCrossRefGoogle Scholar
  18. 18.
    Bonser RS, Taylor R, Collett D, Thomas HL, Dark JH, Neuberger J, Cardiothoracic Advisory Group to NHS Blood and Transplant and the Association of Lung Transplant Physicians (UK). Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet. 2012;380(9843):747–55.PubMedCrossRefGoogle Scholar
  19. 19.
    Steen S, Sjoerg T, Pierre L, Liao Q, Eriksson L, Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 2001;357(9259):825–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364(15):1431–40.PubMedCrossRefGoogle Scholar
  21. 21.
  22. 22.
    Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A, Haga H. Current status of organ transplantation in Japan. Am J Transplant. 2012;12(3):523–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Orens JB, Boehler A, Perrot M, Estenne M, Glanville AR, Keshavjee S, Kotloff R, Morton J, Studer SM, Van Raemdonck D, Waddel T, Snell GI. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant. 2003;22:1183–200.PubMedCrossRefGoogle Scholar
  24. 24.
    Pierre AF, Sekine Y, Hutcheon MA, Waddell TK, Keshavjee SH. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg. 2002;123(3):421–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Steen S, Sjoerg T, Ingemansson R, Lindberg L. Efficacy of topical cooling in lung preservation: is a reappraisal due? Ann Thorac Surg. 1994;58(6):1657–63.PubMedCrossRefGoogle Scholar
  26. 26.
    Fisher AJ, Donnelly SC, Hirani N, Haslett C, Strieter RM, Dark JH, Corris PA. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 2001;163(1):259–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Kaneda H, Waddell TK, de Perrot M, Bai XH, Gutierrez C, Arenovich T, Chaparro C, Liu M, Keshavjee S. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am J Transplant. 2006;6(3):544–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest. 2000;118(5):1255–562.PubMedCrossRefGoogle Scholar
  29. 29.
    Pizanis N, Heckmann J, Tsagakis K, Tossios P, Massoudy P, Wendt D, Jakob H, Kamler M. Lung transplantation using donors 55 years and older: is it safe or just a way out of organ shortage? Eur J Cardiothorac Surg. 2010;38(2):192–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Stewart S, Ciulli F, Wells F, Wallwork J. Pathology of unused donor lungs. Transplant Proc. 1993;25:1167–8.PubMedGoogle Scholar
  31. 31.
    Ware LB, Fang X, Wang Y, Babcock WD, Jones K, Matthay MA. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant. 2005;24:1650–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Oto T, Rabinov M, Griffiths AP, Whitford H, Levvey BJ, Esmore DS, Williams TJ, Snell GI. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure? J Thorac Cardiovasc Surg. 2005;130:1446–52.PubMedGoogle Scholar
  33. 33.
    Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol. 2002;93:1869–74.PubMedGoogle Scholar
  34. 34.
    Motoyama H, Chen F, Ohsumi A, Hijiya K, Okita K, Nakajima D, Sakamoto J, Yamada T, Sato M, Aoyama A, Bando T, Date H. Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model. J Heart Lung Transplant. 2013;32(5):505–10.PubMedCrossRefGoogle Scholar
  35. 35.
    Warnecke G, Moradiellos J, Tudorache I, Kühn C, Avsar M, Wiegmann B, Sommer W, Ius F, Kunze C, Gottlieb J, Varela A, Haverich A. Normothermic perfusion of donor lungs for preservation and assessment with the organ care system lung before bilateral transplantation: a pilot study of 12 patients. Lancet. 2012;380(9856):1851–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Yasushi Hoshikawa
    • 1
  • Yoshinori Okada
    • 1
  • Tatsuaki Watanabe
    • 1
  • Takashi Kondo
    • 1
  1. 1.Department of Thoracic Surgery, Institute of Development, Aging and CancerTohoku UniversitySendaiJapan

Personalised recommendations